Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Jan;77(1):114-6.
doi: 10.1136/jnnp.2004.056515.

Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy

Y-C Chan  1 , D C Allen, D Fialho, K R Mills, R A C Hughes
Affiliations

Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy

Y-C Chan et al. J Neurol Neurosurg Psychiatry. 2006 Jan.

Abstract

Objective: To discover whether Inflammatory Neuropathy Cause and Treatment Group (INCAT) electrophysiological criteria for demyelinating neuropathy predict response to immunotherapy in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).

Methods: This was a retrospective case note study of patients who had attended Guy's Hospital Peripheral Nerve Clinic between January 2001 and March 2004, been diagnosed as having CIDP, and given treatment with corticosteroids, intravenous immunoglobulin (IVIg), or plasma exchange (PE). Patients' nerve conduction studies (NCS) were reviewed for evidence of demyelination and whether the abnormalities fulfilled modified INCAT electrophysiological criteria. Patients whose NCS fulfilled the criteria were assigned to the neurophysiologically definite CIDP group, while those that did not were labelled as neurophysiologically probable CIDP. Responses to any of the three immunotherapy agents were compared between the two groups.

Results: Out of 50 patients, 27 (54%) were classified as neurophysiologically definite and 23 (46%) as neurophysiologically probable CIDP patients. Twenty (74%) neurophysiologically definite and 17 (73.9%) neurophysiologically probable CIDP patients responded to treatment.

Conclusions: INCAT electrophysiological criteria did not predict a higher rate of response to immunotherapy. Neurophysiologically probable CIDP patients should be given a trial of immunotherapy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: none declared

References

    1. Bromberg M B. Comparison of electrodiagnostic criteria for primary demyelination in chronic polyneuropathy. Muscle Nerve 199114968–976. - PubMed
    1. Van Den Bergh P Y, Pieret F. Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 200429565–574. - PubMed
    1. Magda P, Latov N, Brannagan TH I I I.et al Comparison of electrodiagnostic abnormalities and criteria in a cohort of patients with chronic inflammatory demyelinating polyneuropathy. Arch Neurol 2003601755–1759. - PubMed
    1. Hughes R, Bensa S, Willison H.et al Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 200150195–201. - PubMed
    1. Kleyweg R P, van der Meché F G A, Schmitz P I M. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome. Muscle Nerve 1991141103–1109. - PubMed

Publication types

MeSH terms

Substances